Nicotinic receptor could be target for treatment of lung inflammation
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Tests using mice employed an experimental drug that stimulates a specific type of nicotinic receptor in immune cells; researchers attested the reversion of the inflammation condition. The results of the drug were surprising, given the fact that it simulates acetylcholine, a bronchoconstrictor neurotransmitter inhibited by asthma and DPOC's best-known treatments
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news